Faculty profile

Pablo Rusjan

ResearcherPositron, Emission Tomography (PET Centre)University of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Pablo Rusjan

Researcher

Positron, Emission Tomography (PET Centre)

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2015.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Autism Spectrum Disorder Genetic Polymorphism (Rs6971)High Resolution Research Tomograph (Hrrt)Microglia Activation Neuroinflammation Positron Emission Tomography Translocator Protein 18 Kda [18f]-Feppa

Latest papers

MAO-B status in alcohol use disorder: a [11C]SL25.1188 PET imaging study of putative astrogliosis.
Molecular psychiatry · 2026
Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences.
Biological psychiatry · 2021
Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.
Addiction biology · 2021

All 57 publications

Latest funding

Molecular imaging biomarkers of cognition in Parkinson's disease
CIHR · 2020 · Co-investigator
$1,013,626
Molecular Imaging biomarkers of cognition in Parkinson's disease
CIHR · 2019 · Co-investigator
$100,000
Microglial Activation in Major Depressive Disorder: Relationship to Comorbidity and Loss of Synaptic Density
CIHR · 2019 · Co-investigator
$990,676

All 12 grants and awards

57 publications.

MAO-B status in alcohol use disorder: a [11C]SL25.1188 PET imaging study of putative astrogliosis.

Best LM, Truong J, McCluskey T, Meyer JH, Rusjan P, Dheda SS, Pandian J, Tardelli VS, Rubin-Kahana DS, Rhind SG, Le Foll B, Warsh J, Kish SJ, Boileau I

Molecular psychiatry2026

DOI: 10.1038/s41380-025-03355-9 PMID: 41291188

Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences.

Plavén-Sigray P, Matheson GJ, Coughlin JM, Hafizi S, Laurikainen H, Ottoy J, De Picker L, Rusjan P, Hietala J, Howes OD, Mizrahi R, Morrens M, Pomper MG, Cervenka S

Biological psychiatry2021

DOI: 10.1016/j.biopsych.2020.05.028 PMID: 32682565

Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.

Rathitharan G, Truong J, Tong J, McCluskey T, Meyer JH, Mizrahi R, Warsh J, Rusjan P, Kennedy JL, Houle S, Kish SJ, Boileau I

Addiction biology2021

DOI: 10.1111/adb.12876 PMID: 32017280

Imaging Brain Fatty Acid Amide Hydrolase in Untreated Patients With Psychosis.

Watts JJ, Jacobson MR, Lalang N, Boileau I, Tyndale RF, Kiang M, Ross RA, Houle S, Wilson AA, Rusjan P, Mizrahi R

Biological psychiatry2020

DOI: 10.1016/j.biopsych.2020.03.003 PMID: 32387132

Exploring occupancy of the histamine H3 receptor by pitolisant in humans using PET.

Rusjan P, Sabioni P, Di Ciano P, Mansouri E, Boileau I, Laveillé A, Capet M, Duvauchelle T, Schwartz JC, Robert P, Le Foll B

British journal of pharmacology2020First author

DOI: 10.1111/bph.15067 PMID: 32293706

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.

Vasilevskaya A, Taghdiri F, Multani N, Anor C, Misquitta K, Houle S, Burke C, Tang-Wai D, Lang AE, Fox S, Slow E, Rusjan P, Tartaglia MC

Frontiers in neurology2020

DOI: 10.3389/fneur.2020.00574 PMID: 32754109

Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB.

Best LM, Williams B, Le Foll B, Mansouri E, Bazinet RP, Lin L, De Luca V, Lagzdins D, Rusjan P, Tyndale RF, Wilson AA, Hendershot CS, Heilig M, Houle S, Tong J, Kish SJ, Boileau I

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2020

DOI: 10.1038/s41386-020-0606-2 PMID: 31910433

On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study.

Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte HH, Lanzenberger R, Mossaheb N, Zimprich A, Rusjan P, Dorffner G, Mitterhauser M, Hacker M, Pezawas L, Kasper S, Wadsak W, Praschak-Rieder N, Willeit M

Translational psychiatry2020

DOI: 10.1038/s41398-019-0681-5 PMID: 32066718

Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes.

Vasilevskaya A, Taghdiri F, Burke C, Tarazi A, Naeimi SA, Khodadadi M, Goswami R, Sato C, Grinberg M, Moreno D, Wennberg R, Mikulis D, Green R, Colella B, Davis KD, Rusjan P, Houle S, Tator C, Rogaeva E, Tartaglia MC

NeuroImage. Clinical2020

DOI: 10.1016/j.nicl.2020.102212 PMID: 32097865

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.

Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP

Molecular neurobiology2020

DOI: 10.1007/s12035-019-01714-6 PMID: 31385228

Something wrong or missing on this profile? Suggest a correction

Pablo Rusjan

Research

Latest papers

Latest funding

MAO-B status in alcohol use disorder: a [11C]SL25.1188 PET imaging study of putative astrogliosis.

Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences.

Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.

Imaging Brain Fatty Acid Amide Hydrolase in Untreated Patients With Psychosis.

Exploring occupancy of the histamine H3 receptor by pitolisant in humans using PET.

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.

Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB.

On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study.

Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes.

The Interaction Between Neuroinflammation and &#x3b2;-Amyloid in Cognitive Decline in Parkinson's Disease.

Frequent collaborators

Romina Mizrahi

Isabelle Boileau

Gary Remington

Bernard Le Foll

Robert Chen

Kwame Mckenzie

Paul Sandor

Mario Masellis

Antonio Strafella

Peter Selby

Ariel Graff-Guerrero

Connie Marras

Sarah Duff Canning

Kwame Mckenzie

Michael Kiang

Robin Green

Patricia Di Ciano

Susan Fox

Pablo Rusjan

Oury Monchi

Martin Zack

Clement Hamani

Georg Northoff

Ekaterina Rogaeva

Jens Pruessner

David Mikulis

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.